knowledge -WSS

knowledge

author：hotspot 2025-09-27 13:44:56 Page View：3191

Boston Scientific headquarters -- Health coverage from STAT — Boston Scientific is growing its urology portfolio with the Axonics acquisition. Steven Senne/AP

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.

It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold. Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly.

Boston Scientific has acquired companies across all medtech sectors in the past year. The device maker bought Apollo Endosurgery, a company selling surgical tools to combat obesity, for $615 million in 2023. In September of 2023, Boston Scientific bought pain relief company Relievant for $850 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes
Next article： Duchenne breakthrough therapy leaves behind pioneering families

explore

Florida officials tell state schools to teach AP Psychology 'in its entirety'

1:29.STOCKIMAGE/GettyImagesFloridaEducationCommissionerMannyDiaz,Jr.hasinstructedFloridaschooloffici